Christopher J Green, Jeffrey M Holly, Charlotte E Bolton, Antony Bayer, Shah Ebrahim, John Gallacher, Yoav Ben-Shlomo
{"title":"IGF-I、IGF-II和IGFBP-3在男性肺功能中的作用:Caerphilly前瞻性研究","authors":"Christopher J Green, Jeffrey M Holly, Charlotte E Bolton, Antony Bayer, Shah Ebrahim, John Gallacher, Yoav Ben-Shlomo","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Insulin-like growth factors are peptide hormones that have an endocrine role in the development, growth and repair of human tissues including the respiratory tract. To date, only one population study exists which found positive cross-sectional associations with IGF-I and higher lung volumes. We hypothesised that higher IGF-I, IGF-II, IGFBP-3 and IGF molar ratio would be associated with better cross-sectional and longitudinal lung function. We examined cross-sectional (n=843) and prospective associations (n=717) between IGF-I, IGF-II, IGFBP-3 and IGF molar ratio with lung function in the Caerphilly Prospective Study (CaPS) from blood samples obtained around 1986, with spirometry (forced expiratory volume in one second (FEV1) and forced vital capacity (FVC)) performed in the same year and around 2003. Higher IGF molar ratio was associated with improved FEV1/FEV ratio cross-sectionally in both simple (0.007, 95% CI 0.001-0.013, P=0.02) and fully adjusted (0.001, 95% CI 0.001-0.012, P=0.03) models. With the exception of IGFBP-3 and FEV1/FVC in the simple model (0.009, 95% CI 0.001-0.018, P=0.04) all prospective associations between IGF and spirometric measures were consistent with chance. In this study of men, higher IGF molar ratio was associated with improved cross-sectional lung function, although these findings were not replicated prospectively. Further work is required with repeat IGF sampling during follow up to see if IGF levels play any role in predicting future lung function through the life course. </p>","PeriodicalId":73460,"journal":{"name":"International journal of molecular epidemiology and genetics","volume":"5 2","pages":"112-9"},"PeriodicalIF":0.0000,"publicationDate":"2014-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065399/pdf/ijmeg0005-0112.pdf","citationCount":"0","resultStr":"{\"title\":\"Role of IGF-I, IGF-II and IGFBP-3 in lung function of males: the Caerphilly Prospective Study.\",\"authors\":\"Christopher J Green, Jeffrey M Holly, Charlotte E Bolton, Antony Bayer, Shah Ebrahim, John Gallacher, Yoav Ben-Shlomo\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Insulin-like growth factors are peptide hormones that have an endocrine role in the development, growth and repair of human tissues including the respiratory tract. To date, only one population study exists which found positive cross-sectional associations with IGF-I and higher lung volumes. We hypothesised that higher IGF-I, IGF-II, IGFBP-3 and IGF molar ratio would be associated with better cross-sectional and longitudinal lung function. We examined cross-sectional (n=843) and prospective associations (n=717) between IGF-I, IGF-II, IGFBP-3 and IGF molar ratio with lung function in the Caerphilly Prospective Study (CaPS) from blood samples obtained around 1986, with spirometry (forced expiratory volume in one second (FEV1) and forced vital capacity (FVC)) performed in the same year and around 2003. Higher IGF molar ratio was associated with improved FEV1/FEV ratio cross-sectionally in both simple (0.007, 95% CI 0.001-0.013, P=0.02) and fully adjusted (0.001, 95% CI 0.001-0.012, P=0.03) models. With the exception of IGFBP-3 and FEV1/FVC in the simple model (0.009, 95% CI 0.001-0.018, P=0.04) all prospective associations between IGF and spirometric measures were consistent with chance. In this study of men, higher IGF molar ratio was associated with improved cross-sectional lung function, although these findings were not replicated prospectively. Further work is required with repeat IGF sampling during follow up to see if IGF levels play any role in predicting future lung function through the life course. </p>\",\"PeriodicalId\":73460,\"journal\":{\"name\":\"International journal of molecular epidemiology and genetics\",\"volume\":\"5 2\",\"pages\":\"112-9\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-05-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065399/pdf/ijmeg0005-0112.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International journal of molecular epidemiology and genetics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2014/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of molecular epidemiology and genetics","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2014/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
胰岛素样生长因子是一种肽激素,在包括呼吸道在内的人体组织的发育、生长和修复中具有内分泌作用。迄今为止,只有一项人群研究发现igf - 1与肺体积增大呈正相关。我们假设更高的IGF- i、IGF- ii、IGFBP-3和IGF摩尔比与更好的横断面和纵向肺功能相关。在Caerphilly前瞻性研究(CaPS)中,我们从1986年前后获得的血液样本中检测了IGF- i、IGF- ii、IGFBP-3和IGF摩尔比与肺功能之间的横断面(n=843)和前瞻性关联(n=717),并在同年和2003年前后进行了肺活量测定(一秒钟用力呼气量(FEV1)和用力肺活量(FVC))。在简单模型(0.007,95% CI 0.001-0.013, P=0.02)和完全调整模型(0.001,95% CI 0.001-0.012, P=0.03)中,较高的IGF摩尔比与改善的横截面FEV1/FEV比相关。除了简单模型中的IGFBP-3和FEV1/FVC (0.009, 95% CI 0.001-0.018, P=0.04)外,所有IGF和肺活量测定之间的前瞻性关联都是偶然的。在这项男性研究中,较高的IGF摩尔比与改善的横断面肺功能相关,尽管这些发现没有被前瞻性地重复。进一步的工作需要在随访期间重复IGF采样,以确定IGF水平是否在预测生命过程中未来肺功能方面发挥任何作用。
Role of IGF-I, IGF-II and IGFBP-3 in lung function of males: the Caerphilly Prospective Study.
Insulin-like growth factors are peptide hormones that have an endocrine role in the development, growth and repair of human tissues including the respiratory tract. To date, only one population study exists which found positive cross-sectional associations with IGF-I and higher lung volumes. We hypothesised that higher IGF-I, IGF-II, IGFBP-3 and IGF molar ratio would be associated with better cross-sectional and longitudinal lung function. We examined cross-sectional (n=843) and prospective associations (n=717) between IGF-I, IGF-II, IGFBP-3 and IGF molar ratio with lung function in the Caerphilly Prospective Study (CaPS) from blood samples obtained around 1986, with spirometry (forced expiratory volume in one second (FEV1) and forced vital capacity (FVC)) performed in the same year and around 2003. Higher IGF molar ratio was associated with improved FEV1/FEV ratio cross-sectionally in both simple (0.007, 95% CI 0.001-0.013, P=0.02) and fully adjusted (0.001, 95% CI 0.001-0.012, P=0.03) models. With the exception of IGFBP-3 and FEV1/FVC in the simple model (0.009, 95% CI 0.001-0.018, P=0.04) all prospective associations between IGF and spirometric measures were consistent with chance. In this study of men, higher IGF molar ratio was associated with improved cross-sectional lung function, although these findings were not replicated prospectively. Further work is required with repeat IGF sampling during follow up to see if IGF levels play any role in predicting future lung function through the life course.